House Joint Resolution 98, sponsored by Representative Fritts, urges the United States Congress to mandate that the Department of Veterans Affairs (VA) include COVID-19 treatments and anthrax vaccinations as qualifying conditions for care under the PACT Act. The resolution highlights concerns that many servicemembers were unlawfully compelled to receive these treatments, which were administered under Emergency Use Authorization (EUA) rather than full FDA approval. It emphasizes the historical context of the government's treatment of servicemembers regarding experimental substances and the potential long-term health impacts of these actions.

Additionally, the resolution calls for a comprehensive investigation into the decision-making processes surrounding the administration of these treatments, including identifying responsible parties and assessing the legality of the actions taken. It stresses the importance of ensuring that servicemembers receive the care and benefits they deserve, particularly in light of the PACT Act's provisions for veterans exposed to toxic substances. A certified copy of the resolution is to be sent to key congressional leaders and the Tennessee Congressional delegation.